Literature DB >> 32090354

The ethics of risk displacement in research and public policy.

Gerard Vong1, Meira Levinson2.   

Abstract

We identify three distinct ethical problems that can arise with risk displacement. Risk displacement is the shifting of extant risk from one or more individuals to other individual(s) such that the reduction of risk to the first group is causally implicated in increasing risk to the second group. These problems are: concentration of risk in inequitable ways; transfer of risk to already vulnerable or disadvantaged populations; and exercise of undue influence over potential research participants. The first two arise in both public policy and research initiatives, whereas the third is a special concern that only applies to research initiatives. We argue that when one or more of these is of high magnitude, then the study or policy intervention may be ethically wrong. Finally, we conclude that although some risk displacement is ethically permissible, researchers and policymakers still have ethical reasons to reduce the magnitude of these problems.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  clinical trials; public policy; research ethics; research non-participant; risk assessment; risk displacement; third party consent

Year:  2020        PMID: 32090354      PMCID: PMC8287306          DOI: 10.1111/bioe.12726

Source DB:  PubMed          Journal:  Bioethics        ISSN: 0269-9702            Impact factor:   1.898


  6 in total

1.  What's the price of a research subject? Approaches to payment for research participation.

Authors:  N Dickert; C Grady
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245

2.  Inducement in research.

Authors:  Martin Wilkinson; Andrew Moore
Journal:  Bioethics       Date:  1997-10       Impact factor: 1.898

3.  QALYfying the value of life.

Authors:  J Harris
Journal:  J Med Ethics       Date:  1987-09       Impact factor: 2.903

4.  The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial.

Authors:  Audrey Pettifor; Catherine MacPhail; James P Hughes; Amanda Selin; Jing Wang; F Xavier Gómez-Olivé; Susan H Eshleman; Ryan G Wagner; Wonderful Mabuza; Nomhle Khoza; Chirayath Suchindran; Immitrude Mokoena; Rhian Twine; Philip Andrew; Ellen Townley; Oliver Laeyendecker; Yaw Agyei; Stephen Tollman; Kathleen Kahn
Journal:  Lancet Glob Health       Date:  2016-11-01       Impact factor: 26.763

5.  Community engagement and the human infrastructure of global health research.

Authors:  Katherine F King; Pamela Kolopack; Maria W Merritt; James V Lavery
Journal:  BMC Med Ethics       Date:  2014-12-13       Impact factor: 2.652

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.